25 XP   0   0   10

Inogen Inc
Buy, Hold or Sell?

Let's analyse Inogen together

PenkeI guess you are interested in Inogen Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Inogen Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Inogen Inc

I send you an email if I find something interesting about Inogen Inc.

Quick analysis of Inogen (30 sec.)










What can you expect buying and holding a share of Inogen? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
2.5%

What is your share worth?

Current worth
$8.78
Expected worth in 1 year
$4.81
How sure are you?
72.5%

+ What do you gain per year?

Total Gains per Share
$-3.97
Return On Investment
-56.0%

For what price can you sell your share?

Current Price per Share
$7.09
Expected price per share
$5.09 - $9.955
How sure are you?
50%

1. Valuation of Inogen (5 min.)




Live pricePrice per Share (EOD)

$7.09

Intrinsic Value Per Share

$-49.21 - $-1.56

Total Value Per Share

$-40.43 - $7.22

2. Growth of Inogen (5 min.)




Is Inogen growing?

Current yearPrevious yearGrowGrow %
How rich?$204.8m$340.7m-$92.8m-37.5%

How much money is Inogen making?

Current yearPrevious yearGrowGrow %
Making money-$25.6m-$20.9m-$4.6m-18.2%
Net Profit Margin-32.3%-23.6%--

How much money comes from the company's main activities?

3. Financial Health of Inogen (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#106 / 339

Most Revenue
#93 / 339

Most Profit
#301 / 339

Most Efficient
#199 / 339

What can you expect buying and holding a share of Inogen? (5 min.)

Welcome investor! Inogen's management wants to use your money to grow the business. In return you get a share of Inogen.

What can you expect buying and holding a share of Inogen?

First you should know what it really means to hold a share of Inogen. And how you can make/lose money.

Speculation

The Price per Share of Inogen is $7.09. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Inogen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Inogen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $8.78. Based on the TTM, the Book Value Change Per Share is $-0.99 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.78 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Inogen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.14-16.1%-1.10-15.5%-0.90-12.7%-0.38-5.4%-0.07-1.0%
Usd Book Value Change Per Share-1.11-15.6%-0.99-14.0%-0.78-11.0%-0.23-3.2%0.162.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-1.11-15.6%-0.99-14.0%-0.78-11.0%-0.23-3.2%0.162.3%
Usd Price Per Share5.49-8.69-25.15-38.47-57.81-
Price to Earnings Ratio-1.21--3.08--17.80--39.05--38.13-
Price-to-Total Gains Ratio-4.96--16.78--123.52-102.82-153.67-
Price to Book Ratio0.63-0.79-1.71-2.62-5.92-
Price-to-Total Gains Ratio-4.96--16.78--123.52-102.82-153.67-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share7.09
Number of shares141
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.99-0.23
Usd Total Gains Per Share-0.99-0.23
Gains per Quarter (141 shares)-139.92-31.92
Gains per Year (141 shares)-559.69-127.68
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-560-5700-128-138
20-1119-11300-255-266
30-1679-16900-383-394
40-2239-22500-511-522
50-2798-28100-638-650
60-3358-33700-766-778
70-3918-39300-894-906
80-4478-44900-1021-1034
90-5037-50500-1149-1162
100-5597-56100-1277-1290

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%2.010.00.016.7%6.014.00.030.0%24.016.00.060.0%29.016.00.064.4%
Book Value Change Per Share0.04.00.00.0%3.09.00.025.0%10.010.00.050.0%28.010.02.070.0%31.010.04.068.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%1.00.039.02.5%1.00.044.02.2%
Total Gains per Share0.04.00.00.0%3.09.00.025.0%10.010.00.050.0%29.010.01.072.5%32.010.03.071.1%

Fundamentals of Inogen

About Inogen Inc

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Fundamental data was last updated by Penke on 2024-04-11 11:51:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Inogen Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Inogen earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Inogen to the Medical Devices industry mean.
  • A Net Profit Margin of -35.0% means that $-0.35 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Inogen Inc:

  • The MRQ is -35.0%. The company is making a huge loss. -2
  • The TTM is -32.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-35.0%TTM-32.3%-2.6%
TTM-32.3%YOY-23.6%-8.8%
TTM-32.3%5Y-11.1%-21.2%
5Y-11.1%10Y1.5%-12.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-35.0%-11.2%-23.8%
TTM-32.3%-19.6%-12.7%
YOY-23.6%-14.4%-9.2%
5Y-11.1%-21.3%+10.2%
10Y1.5%-24.8%+26.3%
1.1.2. Return on Assets

Shows how efficient Inogen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Inogen to the Medical Devices industry mean.
  • -8.1% Return on Assets means that Inogen generated $-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Inogen Inc:

  • The MRQ is -8.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -7.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.1%TTM-7.3%-0.8%
TTM-7.3%YOY-4.9%-2.4%
TTM-7.3%5Y-2.3%-5.0%
5Y-2.3%10Y0.6%-2.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.1%-4.0%-4.1%
TTM-7.3%-4.5%-2.8%
YOY-4.9%-4.8%-0.1%
5Y-2.3%-4.0%+1.7%
10Y0.6%-5.2%+5.8%
1.1.3. Return on Equity

Shows how efficient Inogen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Inogen to the Medical Devices industry mean.
  • -13.0% Return on Equity means Inogen generated $-0.13 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Inogen Inc:

  • The MRQ is -13.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -10.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.0%TTM-10.9%-2.1%
TTM-10.9%YOY-6.7%-4.2%
TTM-10.9%5Y-3.4%-7.5%
5Y-3.4%10Y0.6%-4.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.0%-3.9%-9.1%
TTM-10.9%-5.6%-5.3%
YOY-6.7%-5.9%-0.8%
5Y-3.4%-6.1%+2.7%
10Y0.6%-7.1%+7.7%

1.2. Operating Efficiency of Inogen Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Inogen is operating .

  • Measures how much profit Inogen makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Inogen to the Medical Devices industry mean.
  • An Operating Margin of -29.4% means the company generated $-0.29  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Inogen Inc:

  • The MRQ is -29.4%. The company is operating very inefficient. -2
  • The TTM is -12.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-29.4%TTM-12.8%-16.6%
TTM-12.8%YOY4.2%-17.0%
TTM-12.8%5Y-2.2%-10.6%
5Y-2.2%10Y3.0%-5.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.4%-22.8%-6.6%
TTM-12.8%-17.1%+4.3%
YOY4.2%-13.4%+17.6%
5Y-2.2%-19.2%+17.0%
10Y3.0%-24.0%+27.0%
1.2.2. Operating Ratio

Measures how efficient Inogen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.29 means that the operating costs are $1.29 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Inogen Inc:

  • The MRQ is 1.294. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.226. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.294TTM1.226+0.068
TTM1.226YOY1.092+0.134
TTM1.2265Y1.058+0.168
5Y1.05810Y0.980+0.079
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2941.428-0.134
TTM1.2261.426-0.200
YOY1.0921.503-0.411
5Y1.0581.440-0.382
10Y0.9801.371-0.391

1.3. Liquidity of Inogen Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Inogen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 2.86 means the company has $2.86 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Inogen Inc:

  • The MRQ is 2.856. The company is able to pay all its short-term debts. +1
  • The TTM is 3.897. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.856TTM3.897-1.041
TTM3.897YOY5.032-1.135
TTM3.8975Y5.325-1.428
5Y5.32510Y5.382-0.057
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8562.787+0.069
TTM3.8972.763+1.134
YOY5.0323.488+1.544
5Y5.3253.617+1.708
10Y5.3823.514+1.868
1.3.2. Quick Ratio

Measures if Inogen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Inogen to the Medical Devices industry mean.
  • A Quick Ratio of 2.40 means the company can pay off $2.40 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Inogen Inc:

  • The MRQ is 2.396. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.328. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.396TTM3.328-0.932
TTM3.328YOY4.161-0.833
TTM3.3285Y4.742-1.414
5Y4.74210Y5.075-0.333
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3961.539+0.857
TTM3.3281.660+1.668
YOY4.1612.139+2.022
5Y4.7422.300+2.442
10Y5.0752.255+2.820

1.4. Solvency of Inogen Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Inogen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Inogen to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.37 means that Inogen assets are financed with 37.2% credit (debt) and the remaining percentage (100% - 37.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Inogen Inc:

  • The MRQ is 0.372. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.309. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.372TTM0.309+0.063
TTM0.309YOY0.251+0.058
TTM0.3095Y0.249+0.060
5Y0.24910Y0.217+0.032
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3720.389-0.017
TTM0.3090.386-0.077
YOY0.2510.338-0.087
5Y0.2490.442-0.193
10Y0.2170.460-0.243
1.4.2. Debt to Equity Ratio

Measures if Inogen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Inogen to the Medical Devices industry mean.
  • A Debt to Equity ratio of 59.3% means that company has $0.59 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Inogen Inc:

  • The MRQ is 0.593. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.454. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.593TTM0.454+0.139
TTM0.454YOY0.336+0.118
TTM0.4545Y0.337+0.117
5Y0.33710Y0.283+0.053
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5930.559+0.034
TTM0.4540.560-0.106
YOY0.3360.478-0.142
5Y0.3370.624-0.287
10Y0.2830.674-0.391

2. Market Valuation of Inogen Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Inogen generates.

  • Above 15 is considered overpriced but always compare Inogen to the Medical Devices industry mean.
  • A PE ratio of -1.21 means the investor is paying $-1.21 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Inogen Inc:

  • The EOD is -1.557. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.206. Based on the earnings, the company is expensive. -2
  • The TTM is -3.076. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.557MRQ-1.206-0.351
MRQ-1.206TTM-3.076+1.870
TTM-3.076YOY-17.799+14.723
TTM-3.0765Y-39.053+35.977
5Y-39.05310Y-38.126-0.926
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-1.557-1.037-0.520
MRQ-1.206-1.578+0.372
TTM-3.076-2.041-1.035
YOY-17.799-2.971-14.828
5Y-39.053-2.058-36.995
10Y-38.126-1.463-36.663
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Inogen Inc:

  • The EOD is -4.375. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.388. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -8.362. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.375MRQ-3.388-0.987
MRQ-3.388TTM-8.362+4.975
TTM-8.362YOY93.424-101.786
TTM-8.3625Y31.588-39.951
5Y31.58810Y17.081+14.507
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-4.375-1.007-3.368
MRQ-3.388-1.544-1.844
TTM-8.362-3.018-5.344
YOY93.424-6.339+99.763
5Y31.588-4.928+36.516
10Y17.081-4.950+22.031
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Inogen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 0.63 means the investor is paying $0.63 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Inogen Inc:

  • The EOD is 0.808. Based on the equity, the company is cheap. +2
  • The MRQ is 0.625. Based on the equity, the company is cheap. +2
  • The TTM is 0.792. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.808MRQ0.625+0.182
MRQ0.625TTM0.792-0.167
TTM0.792YOY1.713-0.921
TTM0.7925Y2.623-1.831
5Y2.62310Y5.921-3.298
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.8081.987-1.179
MRQ0.6252.379-1.754
TTM0.7922.444-1.652
YOY1.7133.215-1.502
5Y2.6233.833-1.210
10Y5.9214.163+1.758
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Inogen Inc.

3.1. Institutions holding Inogen Inc

Institutions are holding 93.48% of the shares of Inogen Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31BlackRock Inc9.60410.0003224032445279525.3308
2023-12-31Camber Capital Management LLC8.57380.2798200000000
2023-12-31Brown Capital Management, LLC6.68930.12851560409-637732-29.0123
2023-12-31Vanguard Group Inc5.82190.0002135807252980.3916
2023-12-31Morgan Stanley - Brokerage Accounts4.44550.00051036990713815220.8757
2023-12-31Ameriprise Financial Inc4.11360.001695955928799342.8838
2023-12-31Fred Alger Management, LLC3.39080.0234790971-273175-25.6708
2023-12-31Bridgeway Capital Management, LLC2.62490.0721612300-17500-2.7787
2023-12-31Meros Investment Management, LP2.52771.536589630260.0044
2023-12-31Renaissance Technologies Corp2.36980.00475528008430017.9936
2023-12-31ExodusPoint Capital Management, LP2.20630.0185514665-285342-35.6674
2023-12-31New York State Common Retirement Fund2.17210.0039506675-31-0.0061
2023-12-31Geode Capital Management, LLC2.15280.0003502184246025.1514
2023-12-31AQR Capital Management LLC2.12160.0051494891-111806-18.4286
2023-12-31State Street Corporation2.07160.00014832425185912.0216
2023-12-31Kent Lake Capital LLC1.95270.9657455494-7636-1.6488
2023-12-31Susquehanna International Group, LLP1.80930.0004422059367710676.5718
2023-12-31Acadian Asset Management LLC1.79880.0089419591297997.6448
2023-09-30Jacobs Levy Equity Management, Inc.1.71190.0124399323154714.0305
2023-12-31Dimensional Fund Advisors, Inc.1.62970.0006380168-47500-11.1067
Total 69.78823.06316279347+652946+4.0%

3.2. Funds holding Inogen Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Brown Capital Mgmt Small Co Inv3.30050.117476990000
2024-02-29Vanguard Total Stock Mkt Idx Inv3.140.000373245600
2024-02-29Columbia Small Cap Value I A2.70950.3158632037553109.5903
2024-03-28iShares Russell 2000 ETF2.56780.00745989802880.0481
2023-12-31Columbia Small Cap Value I2.45570.230457282766001.1656
2023-12-31Bridgeway Small Cap Value2.27720.50755312005000010.3907
2023-12-31Bridgeway Small-Cap Value2.27720.50275312005000010.3907
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.47080.0022343091118003.5618
2024-02-29Columbia VP Small Cap Value 11.07650.31492511082429010.709
2024-01-31Alger Weatherbie Specialized Growth A1.01470.30923668700
2023-12-31Federated Hermes MDT Small Cap Core IS1.00150.1087233629187841410.2407
2023-12-31Federated Hermes MDT SCC Institutional1.00150.1084233629187841410.2407
2024-01-31Fidelity Small Cap Index0.99570.006723227037391.6361
2024-03-28iShares Russell 2000 Value ETF0.96740.0145225673-143-0.0633
2023-12-31Acuitas US Microcap Strategy0.81380.277518983200
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.66590.002515533227001.769
2023-12-31Brown Capital Small Company0.61030.269414235300
2024-02-29JPMorgan US Small Company L0.52260.08261219021219020
2023-12-31Vanguard Strategic Small-Cap Equity Inv0.48830.04211391600
2024-02-29Fidelity Extended Market Index0.40920.001795457-33781-26.1386
Total 29.76613.22166943479+668387+9.6%

3.3. Insider Transactions

Insiders are holding 0.919% of the shares of Inogen Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-03-03Ray Benjamin M AndersonSELL451634.68
2021-08-16Raymond HuggenbergerSELL659462.69
2021-08-02Alison BauerleinSELL139780.33
2021-07-30Alison BauerleinSELL823580.01
2021-07-27Alison BauerleinSELL963275.02
2021-07-27Brenton TaylorSELL794275.02
2021-07-15Raymond HuggenbergerSELL700065.83
2021-06-15Raymond HuggenbergerSELL708763.81
2021-06-02Holdings A/s NovoSELL68000057.32
2021-04-15Brenton TaylorSELL284165.21
2021-04-13Alison BauerleinSELL120060
2021-04-13Brenton TaylorSELL183860

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Inogen Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.107-0.992-10%-0.780-29%-0.226-80%0.159-795%
Book Value Per Share--8.78010.626-17%14.608-40%14.119-38%10.807-19%
Current Ratio--2.8563.897-27%5.032-43%5.325-46%5.382-47%
Debt To Asset Ratio--0.3720.309+20%0.251+48%0.249+49%0.217+71%
Debt To Equity Ratio--0.5930.454+31%0.336+76%0.337+76%0.283+109%
Dividend Per Share----0%-0%-0%0.001-100%
Eps---1.138-1.098-4%-0.898-21%-0.380-67%-0.070-94%
Free Cash Flow Per Share---0.405-0.324-20%-0.630+55%-0.077-81%0.118-444%
Free Cash Flow To Equity Per Share---0.406-0.314-23%-0.626+54%-0.027-93%0.176-331%
Gross Profit Margin--1.9662.418-19%4.714-58%5.128-62%2.579-24%
Intrinsic Value_10Y_max---1.563--------
Intrinsic Value_10Y_min---49.215--------
Intrinsic Value_1Y_max--0.381--------
Intrinsic Value_1Y_min---1.911--------
Intrinsic Value_3Y_max--0.734--------
Intrinsic Value_3Y_min---8.392--------
Intrinsic Value_5Y_max--0.594--------
Intrinsic Value_5Y_min---17.728--------
Market Cap165387012.000+23%128064132.000202593258.000-37%586610703.000-78%897312015.600-86%1348522308.000-91%
Net Profit Margin---0.350-0.323-8%-0.236-33%-0.111-68%0.015-2380%
Operating Margin---0.294-0.128-56%0.042-793%-0.022-93%0.030-1093%
Operating Ratio--1.2941.226+6%1.092+19%1.058+22%0.980+32%
Pb Ratio0.808+23%0.6250.792-21%1.713-64%2.623-76%5.921-89%
Pe Ratio-1.557-29%-1.206-3.076+155%-17.799+1376%-39.053+3139%-38.126+3062%
Price Per Share7.090+23%5.4908.685-37%25.148-78%38.467-86%57.810-91%
Price To Free Cash Flow Ratio-4.375-29%-3.388-8.362+147%93.424-104%31.588-111%17.081-120%
Price To Total Gains Ratio-6.406-29%-4.960-16.781+238%-123.515+2390%102.819-105%153.675-103%
Quick Ratio--2.3963.328-28%4.161-42%4.742-49%5.075-53%
Return On Assets---0.081-0.073-10%-0.049-39%-0.023-71%0.006-1471%
Return On Equity---0.130-0.109-16%-0.067-49%-0.034-74%0.006-2191%
Total Gains Per Share---1.107-0.992-10%-0.780-29%-0.226-80%0.160-791%
Usd Book Value--204812000.000247879500.000-17%340767500.000-40%329346550.000-38%252094475.000-19%
Usd Book Value Change Per Share---1.107-0.992-10%-0.780-29%-0.226-80%0.159-795%
Usd Book Value Per Share--8.78010.626-17%14.608-40%14.119-38%10.807-19%
Usd Dividend Per Share----0%-0%-0%0.001-100%
Usd Eps---1.138-1.098-4%-0.898-21%-0.380-67%-0.070-94%
Usd Free Cash Flow---9450000.000-7561250.000-20%-14688500.000+55%-1796900.000-81%2745800.000-444%
Usd Free Cash Flow Per Share---0.405-0.324-20%-0.630+55%-0.077-81%0.118-444%
Usd Free Cash Flow To Equity Per Share---0.406-0.314-23%-0.626+54%-0.027-93%0.176-331%
Usd Market Cap165387012.000+23%128064132.000202593258.000-37%586610703.000-78%897312015.600-86%1348522308.000-91%
Usd Price Per Share7.090+23%5.4908.685-37%25.148-78%38.467-86%57.810-91%
Usd Profit---26555000.000-25612250.000-4%-20943000.000-21%-8871650.000-67%-1223075.000-95%
Usd Revenue--75896000.00078915000.000-4%94310250.000-20%86066700.000-12%69868725.000+9%
Usd Total Gains Per Share---1.107-0.992-10%-0.780-29%-0.226-80%0.160-791%
 EOD+5 -3MRQTTM+3 -31YOY+9 -255Y+3 -3110Y+4 -32

4.2. Fundamental Score

Let's check the fundamental score of Inogen Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.557
Price to Book Ratio (EOD)Between0-10.808
Net Profit Margin (MRQ)Greater than0-0.350
Operating Margin (MRQ)Greater than0-0.294
Quick Ratio (MRQ)Greater than12.396
Current Ratio (MRQ)Greater than12.856
Debt to Asset Ratio (MRQ)Less than10.372
Debt to Equity Ratio (MRQ)Less than10.593
Return on Equity (MRQ)Greater than0.15-0.130
Return on Assets (MRQ)Greater than0.05-0.081
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Inogen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.593
Ma 20Greater thanMa 507.216
Ma 50Greater thanMa 1007.607
Ma 100Greater thanMa 2006.749
OpenGreater thanClose6.970
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Tax Provision  14155196-15541360401-934-533
Income Tax Expense  14155196-15541360401-934-533



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets326,194
Total Liabilities121,382
Total Stockholder Equity204,812
 As reported
Total Liabilities 121,382
Total Stockholder Equity+ 204,812
Total Assets = 326,194

Assets

Total Assets326,194
Total Current Assets207,067
Long-term Assets119,127
Total Current Assets
Cash And Cash Equivalents 125,492
Short-term Investments 2,979
Net Receivables 42,241
Inventory 21,840
Other Current Assets 14,515
Total Current Assets  (as reported)207,067
Total Current Assets  (calculated)207,067
+/-0
Long-term Assets
Property Plant Equipment 70,654
Goodwill 10,057
Intangible Assets 34,591
Long-term Assets Other 3,825
Long-term Assets  (as reported)119,127
Long-term Assets  (calculated)119,127
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities72,496
Long-term Liabilities48,886
Total Stockholder Equity204,812
Total Current Liabilities
Short-term Debt 3,653
Accounts payable 27
Other Current Liabilities 60,836
Total Current Liabilities  (as reported)72,496
Total Current Liabilities  (calculated)64,516
+/- 7,980
Long-term Liabilities
Capital Lease Obligations 21,923
Long-term Liabilities  (as reported)48,886
Long-term Liabilities  (calculated)21,923
+/- 26,963
Total Stockholder Equity
Common Stock23
Retained Earnings -116,949
Accumulated Other Comprehensive Income 1,225
Other Stockholders Equity 320,513
Total Stockholder Equity (as reported)204,812
Total Stockholder Equity (calculated)204,812
+/-0
Other
Capital Stock23
Cash and Short Term Investments 128,471
Common Stock Shares Outstanding 23,313
Current Deferred Revenue7,980
Liabilities and Stockholders Equity 326,194
Net Debt -103,569
Net Invested Capital 204,812
Net Working Capital 134,571
Property Plant and Equipment Gross 118,499
Short Long Term Debt Total 21,923



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-30
> Total Assets 
47,246
47,586
0
0
60,862
82,397
82,397
145,466
137,153
140,085
140,085
157,199
157,471
161,314
168,400
182,786
194,791
214,049
227,629
251,230
269,841
275,072
299,882
332,636
357,112
375,898
388,195
403,773
444,732
447,339
459,121
458,121
460,331
461,852
476,475
498,174
512,857
489,513
474,616
470,069
469,584
405,041
385,674
374,351
343,696
326,194
326,194343,696374,351385,674405,041469,584470,069474,616489,513512,857498,174476,475461,852460,331458,121459,121447,339444,732403,773388,195375,898357,112332,636299,882275,072269,841251,230227,629214,049194,791182,786168,400161,314157,471157,199140,085140,085137,153145,46682,39782,39760,8620047,58647,246
   > Total Current Assets 
0
26,670
0
0
31,596
32,830
32,830
97,694
89,315
92,543
92,543
109,442
114,436
114,844
123,980
142,561
158,077
161,545
176,504
198,847
219,779
228,488
251,054
282,994
299,550
314,583
321,756
340,726
289,836
292,219
302,989
302,765
303,381
305,697
309,676
327,566
335,831
329,186
318,122
315,447
317,776
304,645
283,147
269,223
225,268
207,067
207,067225,268269,223283,147304,645317,776315,447318,122329,186335,831327,566309,676305,697303,381302,765302,989292,219289,836340,726321,756314,583299,550282,994251,054228,488219,779198,847176,504161,545158,077142,561123,980114,844114,436109,44292,54392,54389,31597,69432,83032,83031,5960026,6700
       Cash And Cash Equivalents 
17,098
15,112
0
0
17,059
13,521
13,521
69,046
56,160
56,836
56,836
51,822
55,090
66,106
72,400
84,500
86,009
92,851
105,105
114,711
129,693
142,953
154,284
166,344
176,282
196,634
190,236
213,947
156,131
198,037
208,362
214,086
213,984
211,962
220,014
238,850
241,576
235,524
213,399
223,621
209,633
187,014
164,137
167,687
124,608
125,492
125,492124,608167,687164,137187,014209,633223,621213,399235,524241,576238,850220,014211,962213,984214,086208,362198,037156,131213,947190,236196,634176,282166,344154,284142,953129,693114,711105,10592,85186,00984,50072,40066,10655,09051,82256,83656,83656,16069,04613,52113,52117,0590015,11217,098
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
14,240
19,028
16,793
13,694
13,616
22,331
21,033
23,135
29,498
33,395
30,991
34,012
42,068
47,574
43,715
49,011
42,202
44,514
11,057
0
4,549
6,525
19,257
13,136
11,106
3,552
9,989
9,989
0
0
0
10,428
2,459
13,432
2,979
2,97913,4322,45910,4280009,9899,9893,55211,10613,13619,2576,5254,549011,05744,51442,20249,01143,71547,57442,06834,01230,99133,39529,49823,13521,03322,33113,61613,69416,79319,02814,24000000000000
       Net Receivables 
0
7,031
0
0
9,707
10,318
10,318
15,645
18,061
21,478
21,478
26,913
23,051
22,030
25,906
29,065
31,329
31,261
31,489
36,303
36,292
32,757
35,680
40,127
36,606
39,696
44,080
49,471
44,047
37,301
43,159
31,406
34,796
31,765
40,409
38,928
34,692
25,795
35,418
32,816
52,112
64,351
55,744
52,956
48,850
42,241
42,24148,85052,95655,74464,35152,11232,81635,41825,79534,69238,92840,40931,76534,79631,40643,15937,30144,04749,47144,08039,69636,60640,12735,68032,75736,29236,30331,48931,26131,32929,06525,90622,03023,05126,91321,47821,47818,06115,64510,31810,3189,707007,0310
       Other Current Assets 
592
309
0
0
450
4,743
531
1,126
980
1,637
1,122
1,723
1,896
870
1,185
2,363
1,470
1,659
2,432
2,030
3,186
2,584
3,778
6,667
8,066
7,108
9,263
10,269
10,716
10,160
13,868
16,544
18,856
17,898
9,723
11,457
24,226
26,005
25,238
27,184
20,306
19,187
14,016
15,377
14,363
14,515
14,51514,36315,37714,01619,18720,30627,18425,23826,00524,22611,4579,72317,89818,85616,54413,86810,16010,71610,2699,2637,1088,0666,6673,7782,5843,1862,0302,4321,6591,4702,3631,1858701,8961,7231,1221,6379801,1265314,74345000309592
   > Long-term Assets 
0
20,916
0
0
29,266
49,567
49,567
47,772
47,838
47,542
47,542
47,757
43,035
46,470
44,420
40,225
36,714
52,504
51,125
52,383
50,062
46,584
48,828
49,642
57,562
61,315
66,439
63,047
154,896
155,120
156,132
155,356
156,950
156,155
166,799
170,608
177,026
160,327
156,494
154,622
151,808
100,396
102,527
105,128
118,428
119,127
119,127118,428105,128102,527100,396151,808154,622156,494160,327177,026170,608166,799156,155156,950155,356156,132155,120154,89663,04766,43961,31557,56249,64248,82846,58450,06252,38351,12552,50436,71440,22544,42046,47043,03547,75747,54247,54247,83847,77249,56749,56729,2660020,9160
       Property Plant Equipment 
18,423
20,279
0
0
28,562
29,722
29,722
30,650
31,057
31,927
31,927
32,174
31,709
30,680
29,644
28,440
26,835
25,199
23,798
21,961
20,951
20,103
20,898
21,972
23,015
22,341
27,934
26,822
26,243
25,293
27,784
30,984
34,638
37,057
48,574
60,667
62,896
63,838
63,409
63,902
63,111
64,922
67,050
69,462
70,709
70,654
70,65470,70969,46267,05064,92263,11163,90263,40963,83862,89660,66748,57437,05734,63830,98427,78425,29326,24326,82227,93422,34123,01521,97220,89820,10320,95121,96123,79825,19926,83528,44029,64430,68031,70932,17431,92731,92731,05730,65029,72229,72228,5620020,27918,423
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,253
2,330
2,363
2,430
2,304
2,288
2,257
2,212
2,242
33,277
32,954
32,912
32,957
33,054
33,165
33,055
33,085
33,028
32,979
32,934
32,803
32,674
32,852
32,887
32,889
9,869
10,057
10,0579,86932,88932,88732,85232,67432,80332,93432,97933,02833,08533,05533,16533,05432,95732,91232,95433,2772,2422,2122,2572,2882,3042,4302,3632,3302,2530000000000000000000
       Intangible Assets 
638
558
0
0
362
215
215
315
274
270
270
238
227
229
206
184
268
241
214
1,684
1,650
4,717
4,456
4,093
4,103
3,755
3,411
3,127
79,536
77,533
75,282
73,253
71,009
68,797
66,557
64,424
62,299
60,147
58,000
55,850
53,700
177
0
0
34,067
34,591
34,59134,0670017753,70055,85058,00060,14762,29964,42466,55768,79771,00973,25375,28277,53379,5363,1273,4113,7554,1034,0934,4564,7171,6501,68421424126818420622922723827027027431521521536200558638
       Long-term Assets Other 
0
79
0
0
342
1,765
1,765
80
80
97
97
97
97
97
96
97
97
410
405
493
512
765
610
537
1,874
2,832
3,586
4,793
4,664
4,888
5,502
4,394
4,166
2,669
2,619
3,261
3,322
3,363
2,151
2,067
2,323
2,445
2,590
2,777
3,783
3,825
3,8253,7832,7772,5902,4452,3232,0672,1513,3633,3223,2612,6192,6694,1664,3945,5024,8884,6644,7933,5862,8321,874537610765512493405410979796979797979780801,7651,76534200790
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
16,427
15,248
15,248
15,248
11,002
15,464
14,474
11,504
9,514
26,654
26,708
25,992
24,619
18,636
20,434
20,736
26,282
30,130
29,296
26,063
11,176
14,452
14,652
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000014,65214,45211,17626,06329,29630,13026,28220,73620,43418,63624,61925,99226,70826,6549,51411,50414,47415,46411,00215,24815,24815,24816,42700000000
> Total Liabilities 
19,043
19,011
0
0
26,667
26,098
26,098
34,652
23,247
21,935
21,935
29,282
27,549
27,296
30,211
35,283
38,709
31,961
34,854
43,453
48,555
48,031
53,545
65,730
65,848
65,474
66,301
69,975
101,586
102,718
111,821
107,007
107,831
112,229
120,191
127,258
121,937
119,286
116,331
113,532
118,742
107,635
104,377
99,572
113,066
121,382
121,382113,06699,572104,377107,635118,742113,532116,331119,286121,937127,258120,191112,229107,831107,007111,821102,718101,58669,97566,30165,47465,84865,73053,54548,03148,55543,45334,85431,96138,70935,28330,21127,29627,54929,28221,93521,93523,24734,65226,09826,09826,6670019,01119,043
   > Total Current Liabilities 
12,809
13,790
0
0
19,244
19,671
19,671
26,300
20,475
18,735
18,735
25,088
22,837
22,013
24,044
27,977
30,228
22,845
25,289
32,190
35,433
33,886
37,667
47,232
46,130
46,585
43,752
46,362
50,043
50,181
55,845
50,614
51,971
56,710
55,472
61,840
59,933
61,512
59,823
59,340
65,736
65,349
63,379
59,367
60,382
72,496
72,49660,38259,36763,37965,34965,73659,34059,82361,51259,93361,84055,47256,71051,97150,61455,84550,18150,04346,36243,75246,58546,13047,23237,66733,88635,43332,19025,28922,84530,22827,97724,04422,01322,83725,08818,73518,73520,47526,30019,67119,67119,2440013,79012,809
       Short-term Debt 
0
3,879
0
0
5,379
5,258
5,258
7,080
267
299
299
307
311
315
238
159
80
-7,057
0
0
0
-11,085
0
0
0
-13,066
2,061
2,006
2,193
2,014
1,863
1,823
1,890
1,931
2,475
3,562
3,518
3,393
3,401
3,506
3,486
3,515
3,570
3,622
3,894
3,653
3,6533,8943,6223,5703,5153,4863,5063,4013,3933,5183,5622,4751,9311,8901,8231,8632,0142,1932,0062,061-13,066000-11,085000-7,057801592383153113072992992677,0805,2585,2585,379003,8790
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
299
0
0
0
315
0
159
80
0
0
0
0
0
0
0
0
0
2,061
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000002,061000000000801590315000299000000000
       Accounts payable 
7,954
8,335
0
0
11,500
9,219
12,117
12,355
11,201
16,120
11,273
17,181
14,303
7,448
8,504
11,058
10,214
12,795
8,885
11,990
11,033
20,626
13,589
17,823
13,134
26,786
14,499
16,071
18,469
30,730
18,727
13,189
9,514
33,712
14,606
15,560
15,939
25,689
18,109
11,906
33,512
33,974
32,183
27,612
30,413
27
2730,41327,61232,18333,97433,51211,90618,10925,68915,93915,56014,60633,7129,51413,18918,72730,73018,46916,07114,49926,78613,13417,82313,58920,62611,03311,9908,88512,79510,21411,0588,5047,44814,30317,18111,27316,12011,20112,35512,1179,21911,500008,3357,954
       Other Current Liabilities 
1,253
482
0
0
978
3,707
809
4,881
7,048
2,316
4,847
5,322
5,811
11,927
13,090
14,442
17,899
14,868
13,644
16,615
20,754
20,812
20,926
26,026
29,447
28,414
21,909
22,669
23,546
11,959
29,298
29,336
33,939
14,073
30,899
34,705
32,052
23,862
29,624
34,921
19,619
18,980
18,832
19,437
17,596
60,836
60,83617,59619,43718,83218,98019,61934,92129,62423,86232,05234,70530,89914,07333,93929,33629,29811,95923,54622,66921,90928,41429,44726,02620,92620,81220,75416,61513,64414,86817,89914,44213,09011,9275,8115,3224,8472,3167,0484,8818093,707978004821,253
   > Long-term Liabilities 
0
5,221
0
0
7,423
6,427
6,427
8,352
2,772
3,200
3,200
4,194
4,712
5,283
6,167
7,306
8,481
9,116
9,565
11,263
13,122
14,145
15,878
18,498
19,718
18,889
22,549
23,613
51,543
52,537
55,976
56,393
55,860
55,519
64,719
65,418
62,004
57,774
56,508
54,192
53,006
42,286
40,998
40,205
52,684
48,886
48,88652,68440,20540,99842,28653,00654,19256,50857,77462,00465,41864,71955,51955,86056,39355,97652,53751,54323,61322,54918,88919,71818,49815,87814,14513,12211,2639,5659,1168,4817,3066,1675,2834,7124,1943,2003,2002,7728,3526,4276,4277,423005,2210
       Long term Debt Total 
0
0
0
0
0
0
4,151
6,333
391
315
237
159
80
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000801592373153916,3334,151000000
       Capital Lease Obligations Min Short Term Debt
0
-3,879
0
0
-5,379
-5,258
-5,258
-7,080
-267
-299
-299
-307
-311
-315
-238
-159
-80
7,057
0
0
0
11,085
0
0
0
13,066
4,920
4,456
5,123
4,702
9,116
8,693
8,570
8,078
16,435
24,911
24,121
23,281
22,409
21,678
20,662
19,764
19,179
18,257
18,873
18,270
18,27018,87318,25719,17919,76420,66221,67822,40923,28124,12124,91116,4358,0788,5708,6939,1164,7025,1234,4564,92013,06600011,0850007,057-80-159-238-315-311-307-299-299-267-7,080-5,258-5,258-5,37900-3,8790
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
16,427
15,248
15,248
15,248
11,002
15,464
14,474
11,504
9,514
26,654
26,708
25,992
24,619
18,636
20,434
20,736
26,282
30,130
29,296
26,063
11,176
14,452
14,652
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000014,65214,45211,17626,06329,29630,13026,28220,73620,43418,63624,61925,99226,70826,6549,51411,50414,47415,46411,00215,24815,24815,24816,42700000000
       Long-term Liabilities Other 
0
0
0
0
0
0
431
473
503
709
820
880
937
1,084
1,399
1,687
2,138
2,074
2,423
2,939
4,086
4,395
5,129
18,158
19,380
18,657
22,322
23,383
51,322
52,450
55,891
56,306
55,769
55,494
64,695
19,165
61,980
57,774
56,508
54,192
53,006
42,286
40,998
0
3,178
0
03,178040,99842,28653,00654,19256,50857,77461,98019,16564,69555,49455,76956,30655,89152,45051,32223,38322,32218,65719,38018,1585,1294,3954,0862,9392,4232,0742,1381,6871,3991,084937880820709503473431000000
       Deferred Long Term Liability 
0
0
0
0
0
0
1,104
1,546
1,878
2,176
2,469
3,155
3,695
4,199
4,768
5,619
6,343
7,042
7,142
8,324
9,036
9,750
10,749
340
338
232
227
230
221
87
85
87
91
25
24
25
24
0
0
0
0
0
0
0
0
0
000000000242524259187858722123022723233834010,7499,7509,0368,3247,1427,0426,3435,6194,7684,1993,6953,1552,4692,1761,8781,5461,104000000
> Total Stockholder Equity
28,203
28,575
0
0
34,195
56,299
56,299
110,814
113,906
118,150
118,150
127,917
129,922
134,018
138,189
147,503
156,082
182,088
192,775
207,777
221,286
227,041
246,337
266,906
291,264
310,424
321,894
333,798
343,146
344,621
347,300
351,114
352,500
349,623
356,284
370,916
390,920
370,227
358,285
356,537
350,842
297,406
281,297
274,779
230,630
204,812
204,812230,630274,779281,297297,406350,842356,537358,285370,227390,920370,916356,284349,623352,500351,114347,300344,621343,146333,798321,894310,424291,264266,906246,337227,041221,286207,777192,775182,088156,082147,503138,189134,018129,922127,917118,150118,150113,906110,81456,29956,29934,1950028,57528,203
   Common Stock
1
1
0
0
1
1
1
18
18
19
19
19
19
20
20
20
20
20
20
21
21
21
21
21
21
22
22
22
22
22
22
22
22
22
22
23
23
23
23
23
23
23
23
23
23
23
2323232323232323232323222222222222222222222121212121212020202020201919191918181110011
   Retained Earnings Total Equity
0
0
0
0
0
0
-62,631
-60,345
-58,212
-56,693
-55,121
-51,662
-48,966
-45,108
-42,743
-37,601
-34,146
-12,363
-6,431
1,907
9,245
8,639
19,397
34,007
50,439
60,484
65,786
75,946
82,809
81,434
79,845
82,425
80,726
75,605
74,873
79,975
92,149
69,272
55,058
51,616
42,110
-14,500
-34,849
0
0
0
000-34,849-14,50042,11051,61655,05869,27292,14979,97574,87375,60580,72682,42579,84581,43482,80975,94665,78660,48450,43934,00719,3978,6399,2451,907-6,431-12,363-34,146-37,601-42,743-45,108-48,966-51,662-55,121-56,693-58,212-60,345-62,631000000
   Accumulated Other Comprehensive Income 
0
-10,639
0
0
-15,410
-15,956
-15,956
-20,917
-23,640
-25,840
-25,840
-31,086
-33,875
-37
-118
-2
6
-35
26
-34
203
272
284
999
703
724
860
653
244
-87
422
318
407
475
925
1,303
1,651
1,469
1,184
-41
-431
-243
-4
74
-583
1,225
1,225-58374-4-243-431-411,1841,4691,6511,303925475407318422-87244653860724703999284272203-3426-356-2-118-37-33,875-31,086-25,840-25,840-23,640-20,917-15,956-15,956-15,41000-10,6390
   Capital Surplus 
0
0
0
0
0
0
170,517
171,141
172,100
174,824
177,668
179,560
178,869
179,143
181,030
185,086
190,202
194,466
199,160
205,883
211,817
218,109
226,635
231,879
240,101
249,194
255,226
257,177
260,071
263,252
267,011
268,349
271,345
273,521
280,464
289,615
297,097
299,463
302,020
304,939
309,140
312,126
316,127
0
0
0
000316,127312,126309,140304,939302,020299,463297,097289,615280,464273,521271,345268,349267,011263,252260,071257,177255,226249,194240,101231,879226,635218,109211,817205,883199,160194,466190,202185,086181,030179,143178,869179,560177,668174,824172,100171,141170,517000000
   Treasury Stock000000000000000000000000000000000000000-107,904000000
   Other Stockholders Equity 
0
10,639
0
0
15,410
15,956
15,956
46,592
58,587
-37
200,664
210,646
212,744
179,143
181,030
185,086
190,202
194,466
199,160
205,883
211,817
218,109
226,635
231,879
240,101
249,194
255,226
257,177
260,071
263,252
267,011
268,349
271,345
273,521
280,464
289,615
297,097
299,463
302,020
304,939
309,140
312,126
316,127
319,357
321,584
320,513
320,513321,584319,357316,127312,126309,140304,939302,020299,463297,097289,615280,464273,521271,345268,349267,011263,252260,071257,177255,226249,194240,101231,879226,635218,109211,817205,883199,160194,466190,202185,086181,030179,143212,744210,646200,664-3758,58746,59215,95615,95615,4100010,6390



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue315,660
Cost of Revenue-179,118
Gross Profit136,542136,542
 
Operating Income (+$)
Gross Profit136,542
Operating Expense-200,926
Operating Income-64,384-64,384
 
Operating Expense (+$)
Research Development20,840
Selling General Administrative75,260
Selling And Marketing Expenses107,091
Operating Expense200,926203,191
 
Net Interest Income (+$)
Interest Income6,687
Interest Expense-0
Other Finance Cost-0
Net Interest Income6,687
 
Pretax Income (+$)
Operating Income-64,384
Net Interest Income6,687
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-102,344-26,424
EBIT - interestExpense = -64,384
-102,344
-102,449
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-64,384-102,344
Earnings Before Interest and Taxes (EBITDA)-46,232
 
After tax Income (+$)
Income Before Tax-102,344
Tax Provision-779
Net Income From Continuing Ops-132,504-103,123
Net Income-102,449
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses380,044
Total Other Income/Expenses Net-37,960-6,687
 

Technical Analysis of Inogen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Inogen. The general trend of Inogen is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Inogen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Inogen Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 7.95 < 8.19 < 9.955.

The bearish price targets are: 6.14 > 5.82 > 5.09.

Tweet this
Inogen Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Inogen Inc. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Inogen Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Inogen Inc. The current macd is -0.07059262.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Inogen price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Inogen. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Inogen price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Inogen Inc Daily Moving Average Convergence/Divergence (MACD) ChartInogen Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Inogen Inc. The current adx is 11.61.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Inogen shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Inogen Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Inogen Inc. The current sar is 7.46836628.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Inogen Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Inogen Inc. The current rsi is 48.59. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
Inogen Inc Daily Relative Strength Index (RSI) ChartInogen Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Inogen Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Inogen price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Inogen Inc Daily Stochastic Oscillator ChartInogen Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Inogen Inc. The current cci is -37.86417068.

Inogen Inc Daily Commodity Channel Index (CCI) ChartInogen Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Inogen Inc. The current cmo is -2.69505514.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Inogen Inc Daily Chande Momentum Oscillator (CMO) ChartInogen Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Inogen Inc. The current willr is -50.77720207.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Inogen is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Inogen Inc Daily Williams %R ChartInogen Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Inogen Inc.

Inogen Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Inogen Inc. The current atr is 0.50918206.

Inogen Inc Daily Average True Range (ATR) ChartInogen Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Inogen Inc. The current obv is 8,694,429.

Inogen Inc Daily On-Balance Volume (OBV) ChartInogen Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Inogen Inc. The current mfi is 39.29.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Inogen Inc Daily Money Flow Index (MFI) ChartInogen Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Inogen Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-31CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-15BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Inogen Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Inogen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.593
Ma 20Greater thanMa 507.216
Ma 50Greater thanMa 1007.607
Ma 100Greater thanMa 2006.749
OpenGreater thanClose6.970
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Inogen with someone you think should read this too:
  • Are you bullish or bearish on Inogen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Inogen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Inogen Inc

I send you an email if I find something interesting about Inogen Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Inogen Inc.

Receive notifications about Inogen Inc in your mailbox!